Blood test for cancer is trialled by NHS Scotland

The NHS in Scotland is to conduct a major screening trial for lung cancer using a new blood test developed by Oncimmune Ltd, a University of Nottingham spinout company. It will be the first time the blood test has been used outside the US.

Appears in issue 57

Tags: Chief Scientific Officer of Oncimmune Ltd, Director of CEAC, EarlyCDT-Lung, lung cancer, Oncimmune Ltd, Professor John Robertson, The Centre of Excellence for Autoimmunity in Cancer (CEAC)